Agarwala S - Search Results

1

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.

Hughes MS, Zager J, Faries M, Alexander HR, Royal RE, Wood B, Choi J, McCluskey K, Whitman E, Agarwala S, Siskin G, Nutting C, Toomey MA, Webb C, Beresnev T, Pingpank JF. Hughes MS, et al. Among authors: agarwala s. Ann Surg Oncol. 2016 Apr;23(4):1309-19. doi: 10.1245/s10434-015-4968-3. Epub 2015 Nov 23. Ann Surg Oncol. 2016. PMID: 26597368 Free PMC article. Clinical Trial.

2

Interferons in the therapy of solid tumors.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Oncology. 1994 Mar-Apr;51(2):129-36. doi: 10.1159/000227327. Oncology. 1994. PMID: 7515168 Review.

3

Potential uses of interferon alpha 2 as adjuvant therapy in cancer.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Ann Surg Oncol. 1995 Jul;2(4):365-71. doi: 10.1007/BF02307071. Ann Surg Oncol. 1995. PMID: 7552628 Review.

4

Interferons in melanoma.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Curr Opin Oncol. 1996 Mar;8(2):167-74. doi: 10.1097/00001622-199603000-00015. Curr Opin Oncol. 1996. PMID: 8727310 Review.

5

Adjuvant therapy of melanoma.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Semin Surg Oncol. 1998 Jun;14(4):302-10. doi: 10.1002/(sici)1098-2388(199806)14:4<302::aid-ssu6>3.0.co;2-6. Semin Surg Oncol. 1998. PMID: 9588723 Review.

6

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.

Agarwala SS, Ferri W, Gooding W, Kirkwood JM. Agarwala SS, et al. Cancer. 1999 May 1;85(9):1979-84. Cancer. 1999. PMID: 10223239 Clinical Trial.

7

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM. Chapman PB, et al. Among authors: agarwala ss. J Clin Oncol. 1999 Sep;17(9):2745-51. doi: 10.1200/JCO.1999.17.9.2745. J Clin Oncol. 1999. PMID: 10561349 Clinical Trial.

8

Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.

Agarwala SS, Glaspy J, O'Day SJ, Mitchell M, Gutheil J, Whitman E, Gonzalez R, Hersh E, Feun L, Belt R, Meyskens F, Hellstrand K, Wood D, Kirkwood JM, Gehlsen KR, Naredi P. Agarwala SS, et al. J Clin Oncol. 2002 Jan 1;20(1):125-33. doi: 10.1200/JCO.2002.20.1.125. J Clin Oncol. 2002. PMID: 11773161 Clinical Trial.

9

Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma: a detailed safety analysis.

O'Day SJ, Agarwala SS, Naredi P, Kass CL, Gehlsen KR, Glaspy J. O'Day SJ, et al. Among authors: agarwala ss. Melanoma Res. 2003 Jun;13(3):307-11. doi: 10.1097/00008390-200306000-00014. Melanoma Res. 2003. PMID: 12777988 Clinical Trial.

10

Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.

Agarwala SS, Neuberg D, Park Y, Kirkwood JM. Agarwala SS, et al. Cancer. 2004 Apr 15;100(8):1692-8. doi: 10.1002/cncr.20166. Cancer. 2004. PMID: 15073858 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

653 results

Search Page